Genmab AS

Genmab AS Current Liabilities

Current Liabilities of Genmab AS (GMAB) as of Nov 22, 2026.

Current Liabilities

-USD

Last updated:

Current Liabilities of Genmab AS is 2026 - USD. Current Liabilities of Genmab AS was 2025 - USD. It decreases by % lower compared to the previous year.

The Genmab AS Current Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Liabilities
Date
Current Liabilities
Jan 1, 2002
146.75 M USD
Jan 1, 2003
63.61 M USD
Jan 1, 2004
58.47 M USD
Jan 1, 2005
237.18 M USD
Jan 1, 2006
185.80 M USD
Jan 1, 2007
1.07 B USD
The Genmab AS Current Liabilities history
YEARCurrent LiabilitiesYoY
1.07 BUSD+474.46%
185.80 MUSD-21.66%
237.18 MUSD+305.66%
58.47 MUSD-8.09%
63.61 MUSD-56.65%
146.75 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Genmab AS Stock analysis

What does Genmab AS do? Genmab AS is a biotechnology company based in Copenhagen, Denmark, operating in the Health Care sector. It develops and markets antibody-based therapies for cancer and other diseases, including EPKINLY, TEPKINLY, and Tivdak for various lymphomas and cervical cancer. The company also advances several product candidates in clinical development, such as Epcoritamab for lymphomas and GEN1059 for solid tumors, alongside established treatments like DARZALEX and TECVAYLI for multiple myeloma and other conditions. Genmab AS is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Genmab AS stock

On Eulerpool you can find the complete historical development of Current Liabilities Genmab AS since 2006 – with annual values, charts, and detailed analysis.

Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.

Current Liabilities's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's Genmab AS historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Genmab AS

All Key Metrics — Genmab AS